Chengyou Du

744 citations
44 papers · 538 indexed · h-index 14

Impact in

  • Hepatology top 5%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
    • Inflammatory Biomarkers in Disease Prognosis
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 18
    • Liver physiology and pathology 4
    • Inflammatory Biomarkers in Disease Prognosis 8
    • Pancreatic and Hepatic Oncology Research 7

Chengyou Du

40 papers receiving 535 citations

Peers

Chengyou Du
Comparison fields: 5 of 61
  • Hepatology 275
  • Oncology 188
  • Cancer Research 102
  • Surgery 194
  • Epidemiology 128
Replace Xiaowei Dang with:
Xiaowei Dang China
Chiara Spoto Italy
Poh Seng Tan Singapore
Pedro Luiz Serrano Usón Brazil
Miho Kanda Japan
Anna Giacomin Italy
Takumi Irie Japan
Yingcheng Lin China
Osamu Okochi Japan
Neus Llarch Spain
Chengyou Du relative to Xiaowei Dang China Xiaowei Dang's profile →
Citations per field
00.5×9.3×
Xiaowei Dang · 1×
Citations per year

Countries citing papers authored by Chengyou Du

Since Specialization
Citations

This map shows the geographic impact of Chengyou Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyou Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyou Du more than expected).

Fields of papers citing papers by Chengyou Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyou Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyou Du. The network helps show where Chengyou Du may publish in the future.

Co-authors

The 25 scholars most cited alongside Chengyou Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chengyou Du Line = papers co-authored together Chengyou Du links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20250
2 20247
3 20240
4 20235
5 20231
6 20224
7 20228
8 20226
9 20217
10 20216
11 20200
12 202016
13 201920
14 20184
15 201825
16 201615
17 20156
18 20135
19 20129
20 201111

About Chengyou Du

Chengyou Du is a scholar working on Hepatology, Oncology, Cancer Research, Surgery and Pathology and Forensic Medicine, having authored 44 papers that have together received 538 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers), Liver Disease Diagnosis and Treatment (7 papers), Pancreatic and Hepatic Oncology Research (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers), Ferroptosis and cancer prognosis (6 papers), Cancer Mechanisms and Therapy (5 papers) and Liver physiology and pathology (4 papers). The work is most often cited by research in Hepatology (275 citations), Oncology (188 citations), Cancer Research (102 citations), Surgery (194 citations) and Epidemiology (128 citations). Chengyou Du has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Jianguo Qiu, Rui Liao, Shuting Chen, Dewei Li, Shiqiao Luo, Ning Jiang, Wei Tang, Jianping Gong, Ping Huang and Ming Li. Their work appears in journals such as Journal of Clinical Oncology, Journal of Surgical Research, Surgical Endoscopy, Oncotarget and World Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026